Tag Archives: healthcare

Europe: Go Easy on Your Pharma Lobbyists

European pharmaceutical executives are sometimes heard to complain that their public affairs departments are not doing a good job for them, and that their industry associations are a waste of time and money. A report published in Brussels earlier this month suggests that this judgment may be excessively harsh. Lobbyists for healthcare and pharmaceuticals score [...]
Posted in Europe, Regulatory | Also tagged , , , | Leave a comment

Upcoming Webcast: The Unvarnished Truth about Comparative Effectiveness

The mere mention of the term “comparative effectiveness” evokes a host of reactions among pharmaceutical manufacturers: confusion, skepticism, even fear. With President Obama calling for a national agency for comparative effectiveness, no one doubts that it is coming to healthcare—but what will it encompass? How will comparative effectiveness impact access to medications? What can manufacturers [...]
Posted in Webcast | Also tagged , , , , , , , , , | Leave a comment

JP Morgan Healthcare Conference:
It’s All About "Money…Rather the Economy!"

JP Morgan’s Healthcare Conference has always been about financing, but money has never been the main focus like it is at this year’s annual gathering in San Francisco. The hallmark of this investment meeting has been innovation, with companies passionately pitching their new product or technology and management team’s capability to execute on a [...]
Posted in Events | Also tagged , , , , , , , , , , , | 1 Comment

Eliminate Waste (Whatever That Is)

There’s a fascinating editorial in this week’s New England Journal of Medicine by Henry J. Aaron, a healthcare economist at the Brookings Institution. Aaron argues that on average healtchare spending is not wasteful, since its benefits exceed its costs. But that doesn’t mean there isn’t waste. The trick, though, is to identify it, and as [...]
Posted in Uncategorized | Also tagged , , | Leave a comment